.webp)
Key takeaways:
- Dysautonomia affects more than 70 million people worldwide and is increasingly recognized as a hidden driver of digestive symptoms that often goes undiagnosed.
- GI involvement is highly prevalent: 46% of patients meet criteria for IBS, and up to 80% of those with hypermobile Ehlers-Danlos report GI symptoms.
- Cases have risen alongside long COVID, with up to 79% of long COVID patients possibly experiencing dysautonomia, often as an invisible illness.
- Best practices pair multidisciplinary care with strategies like increased sodium and fluid intake, compression garments, small frequent meals, and individualized diet modifications.
Dysautonomia is increasingly recognized as a hidden driver of digestive symptoms – from bloating and abdominal pain to severe motility disorders – yet it often goes undiagnosed in gut health practice.
In this webinar, UCLA dietitian and gut health expert Nancee Jaffe unpacks the overlap between autonomic dysfunction and GI conditions, showing why every clinician in the digestive health space should understand this connection.
Download the presentation slides
Dysautonomia affects more than 70 million people worldwide, with postural orthostatic tachycardia syndrome (POTS) the most common form. Cases have risen with long COVID, and many patients experience it as an “invisible illness” despite severe daily symptoms
.webp)
.webp)